Kaiser Permanente/ San Diego

San Diego, California 92123

5 studies enrolling now · 26 studies all time

What they study most

Asthma, Bowel Incontinence, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Clonal Mast Cell Disease, Colorectal Cancer, Critical Limb Ischemia, Delivery Complication, Early Breast Cancer, Fecal Incontinence, Invasive Breast Cancer, KIT D816V Mutation

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations — Recruiting now
• Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence — Recruiting now
• Accelerometer Measured Early Recovery After Prolapse Surgery — Recruiting now
• Training for Urinary Leakage Improvement After Pregnancy — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy — Completed
• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) — Completed
• Neuromodulation for Accidental Bowel Leakage — Completed
• Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence — Status unconfirmed
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• Gentamicin Intravesical Efficacy for Infection of Urinary Tract — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• NSABP Patient Registry and Biospecimen Profiling Repository — Completed
• Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer — Completed
• Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer — Completed
• A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Combined Treatment for Mixed Incontinence — Completed
• Prophylactic Uterosacral Ligament Suspension at the Time of Hysterectomy for Prevention of Vaginal Vault Prolapse — Status unconfirmed
• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed
• Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Outcomes With Learning Curves — Status unconfirmed
• Affixing Polypropylene Mesh Using Barbed Suture (Quill™ Srs) During Laparoscopic Sacrocolpopexy Randomized Controlled Trial (Quill Lsc) — Completed
• A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) — Completed